Boris Azaïs
8 SlideShares 10 Abonné 2 Suivis
Personal Information
Entreprise/Lieu de travail
Paris Area, France, ----------------- France
Profession
Director Public Policy Europe Canada
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
http://www.msd-forum.com
À propos
Conducting advocacy campaigns with European institutions and national governments focusing on health and industrial policy in Europe and Canada. Speaking at international conferences, producing position papers, and coordinating advocacy activities related to the policy framework that supports faster access to medicines and promotes pharmaceutical innovation.
Coordonnées
Mots-clés
pharmaceutical innovation pharma healthcare policy affordability access to medicines innovation competitiveness ip rights budget prices public private partnerships patients rights rna interference vaccines boris azais stefan oschmann ken frazier r&d ecosystem pharmaceutical access to health hepatitis hcv health research and development r&d business model
Tout plus

Présentations

(4)
Tout voir

2013 12 b azais at pan hellenic health-final

il y a 10 ans • 455 Vues

2014 01 Boris Azais - How Pharmaceutical companies are transforming for the future

il y a 10 ans • 1479 Vues

Can we still spend more on health without breaking the budget?

il y a 10 ans • 518 Vues

Broadening the Perspective - Affordability of Medicines - EHFG 2023 presentation by Casper Paardkooper

il y a 6 mois • 30 Vues

Documents

(4)
Tout voir

MSD NOBODY LEFT OUTSIDE ONE PAGER

il y a 5 ans • 33 Vues

EUROHEALTH - Gastein 2017 Edition - Nobody Left Behind - Onyango Schatz Lazarus

il y a 5 ans • 44 Vues

MSD AIA Forum - 2009 Brochure

il y a 2 ans • 114 Vues

MSD Policy Passport on pharmaceutical innovation - October 2023 v2.pdf

il y a 1 mois • 10 Vues
Personal Information
Entreprise/Lieu de travail
Paris Area, France, ----------------- France
Profession
Director Public Policy Europe Canada
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
http://www.msd-forum.com
À propos
Conducting advocacy campaigns with European institutions and national governments focusing on health and industrial policy in Europe and Canada. Speaking at international conferences, producing position papers, and coordinating advocacy activities related to the policy framework that supports faster access to medicines and promotes pharmaceutical innovation.
Mots-clés
pharmaceutical innovation pharma healthcare policy affordability access to medicines innovation competitiveness ip rights budget prices public private partnerships patients rights rna interference vaccines boris azais stefan oschmann ken frazier r&d ecosystem pharmaceutical access to health hepatitis hcv health research and development r&d business model
Tout plus